Comparative gene identification-58/α/β hydrolase domain 5: More than just an adipose triglyceride lipase activator?

Current Opinion in Lipidology

Volumn 25, Issue 2, 2014, Pages 102-109

  Zierler, Kathrin A ^a   Zechner, Rudolf ^a   Haemmerle, Guenter ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cardiomyopathy; Hepatosteatosis; Ichthyosis; Lipid signaling; Lipolysis

Indexed keywords

ACYLTRANSFERASE; COMPARATIVE GENE IDENTIFICATION 58; FAT DROPLET; LYSOPHOSPHATIDIC ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BRAIN; CATABOLISM; ENERGY METABOLISM; EPIDERMIS; HEART MUSCLE; HOMEOSTASIS; HUMAN; KIDNEY; KNOCKOUT MOUSE; LIPID HYDROLYSIS; LIPID LIVER LEVEL; LIPID METABOLISM; LIPOLYSIS; LUNG; MACROPHAGE; MOUSE STRAIN; NONHUMAN; PANCREAS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STOMACH; TESTIS;

MUS;

1-ACYLGLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; ADIPOSE TISSUE; ANIMALS; ENZYME ACTIVATION; HUMANS; LIPASE; LIPOLYSIS; PROTEIN STRUCTURE, TERTIARY;

EID: 84897025645     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000058     Document Type: Review

References (87)

1. Schweiger M, Lass A, Zimmermann R, et al. Neutral lipid storage disease: Genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5. Am J Physiol Endocrinol Metab 2009; 297:E289-E296.
2. Lefevre C, Jobard F, Caux F, et al. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am J Hum Genet 2001; 69:1002-1012.
3. Schrag JD, Cygler M. Lipases and alpha/beta hydrolase fold. Methods Enzymol 1997; 284:85-107.
4. Simon GM, Cravatt BF. Endocannabinoid biosynthesis proceeding through glycerophospho-N-Acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J Biol Chem 2006; 281:26465-26472.
5. Lord CC, Thomas G, Brown JM. Mammalian alpha beta hydrolase domain (ABHD) proteins: Lipid metabolizing enzymes at the interface of cell signaling and energy metabolism. Biochim Biophys Acta 2013; 1831:792-802.
6. Lass A, Zimmermann R, Haemmerle G, et al. Adipose triglyceride lipasemediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome. Cell Metab 2006; 3:309-319.
7. Yamaguchi T, Omatsu N, Morimoto E, et al. CGI-58 facilitates lipolysis on lipid droplets but is not involved in the vesiculation of lipid droplets caused by hormonal stimulation. J Lipid Res 2007; 48:1078-1089.
8. Radner FPW, Streith IE. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58). J Biol Chem 2010; 285:7300-7311.
9. Brown JM, Betters JL, Lord C, et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. J Lipid Res 2010; 51:3306-3315.
10. Lord CC, Betters JL, Ivanova PT, et al. CGI-58/ABHD5-derived signaling lipids regulate systemic inflammation and insulin action. Diabetes 2012; 61:355-363.
11. Cantley JL, Yoshimura T, Camporez JP, et al. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Proc Natl Acad Sci U S A 2013; 110:1869-1874.
12. Haemmerle G, Lass A, Zimmermann R, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312:734-737.
13. Haemmerle G, Moustafa T, Woelkart G, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-Alpha and PGC-1. Nat Med 2011; 17:1076-1085.
14. Caviglia JM, Betters JL, Dapito D, et al. Adipose-selective overexpression of ABHD5/CGI-58 does not increase lipolysis or protect against diet-induced obesity. J Lipid Res 2011; 52:2032-2042.
15. Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes 2009; 58:855-866.
16. Zierler KA, Jaeger D, Pollak NM, et al. Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J Biol Chem 2013; 288:9892-9904.
17. Kienesberger PC, Pulinilkunnil T, Nagendran J, et al. Early structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation. Cardiovasc Res 2013; 99:442-451.
18. Sitnick MT, Basantani MK, Cai L, et al. Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity. Diabetes 2013; 62:3350-3361.
19. Guo F, Ma Y, Kadegowda, et al. Deficiency of liver comparative gene identification-58 causes steatohepatitis and fibrosis in mice. J Lipid Res 2013; 54:2109-2120.
20. Wu JW, Wang SP, Alvarez F, et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology 2011; 54:122-132.
21. Ghosh AK, Ramakrishnan G, Chandramohan C, Rajasekharan R. CGI-58, the causative gene for Chanarin-Dorfman syndrome, mediates acylation of lysophosphatidic acid. J Biol Chem 2008; 283:24525-24533.
22. Montero-Moran G, Caviglia JM, McMahon D, et al. CGI-58/ABHD5 is a coenzyme A-dependent lysophosphatidic acid acyltransferase. J Lipid Res 2010; 51:709-719.
23. Ahmadian M, Wang Y, Sul HS. Lipolysis in adipocytes. Int J Biochem Cell Biol 2010; 42:555-559.
24. Bezaire V, Langin D. Regulation of adipose tissue lipolysis revisited. Proc Nutr Soc 2009; 68:350-360.
25. Watt MJ, Spriet LL. Triacylglycerol lipases and metabolic control: Implications for health and disease. Am J Physiol Endocrinol Metab 2010; 299:E162-E168.
26. Zimmermann R, Lass A, Haemmerle G, Zechner R. Fate of fat: The role of adipose triglyceride lipase in lipolysis. Biochim Biophys Acta 2009; 1791: 494-500.
27. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis: A highly regulated multienzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50:14-27.
28. Zechner R, Zimmermann R, Eichmann TO, et al. FAT SIGNALS: Lipases and lipolysis in lipid metabolism and signaling. Cell Metab 2012; 15:279-291.
29. Lord CC, Brown JM. Distinct roles for alpha-beta hydrolase domain 5 (ABHD5/CGI-58) and adipose triglyceride lipase (ATGL/PNPLA2) in lipid metabolism and signaling. Adipocyte 2012; 1:123-131.
30. Gruber A, Cornaciu I, Lass A, et al. The N-Terminal region of comparative gene identification-58 (CGI-58) is important for lipid droplet binding and activation of adipose triglyceride lipase. J Biol Chem 2010; 285:12289-12298.
31. Schweiger M, Schoiswohl G, Lass A, et al. The C-Terminal region of human adipose triglyceride lipase affects enzyme activity and lipid droplet binding. J Biol Chem 2008; 283:17211-17220.
32. Bezaire V, Mairal A, Anesia R, et al. Chronic TNFalpha and cAMP pretreatment of human adipocytes alter HSL, ATGL and perilipin to regulate basal and stimulated lipolysis. FEBS Lett 2009; 583:3045-3049.
33. Cornaciu I, Boeszoermenyi A, Lindermuth H, et al. The minimal domain of adipose triglyceride lipase (ATGL) ranges until leucine 254 and can be activated and inhibited by CGI-58 and G0S2, respectively. PLoS One 2011; 6:e26349.
34. Granneman JG, Moore HH, Krishnamoorthy R, Rathod M. Perilipin controls lipolysis by regulating the interactions of AB-hydrolase containing 5 (Abhd5) and adipose triglyceride lipase (Atgl). J Biol Chem 2009; 284:34538-34544.
35. Oberer M, Boeszoermenyi A, Nagy HM, Zechner R. Recent insights into the structure and function of comparative gene identification-58. Curr Opin Lipidol 2011; 22:149-158.
36. Eichmann TO, Kumari M, Haas JT, et al. Studies on the substrate and stereo/ regioselectivity of adipose triglyceride lipase, hormone-sensitive lipase, and diacylglycerol-O-Acyltransferases. J Biol Chem 2012; 287:41446-41457.
37. Granneman JG, Moore HH, Granneman RL, et al. Analysis of lipolytic protein trafficking and interactions in adipocytes. J Biol Chem 2007; 282:5726-5735.
38. Granneman JG, Moore HH. Location, location: Protein trafficking and lipolysis in adipocytes. Trends Endocrinol Metab 2008; 19:3-9.
39. Yamaguchi T. Crucial role of CGI-58/alpha/beta hydrolase domain-containing protein 5 in lipid metabolism. Biol Pharm Bull 2010; 33:342-345.
40. Redaelli C, Coleman RA, Moro L, et al. Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: First report of large deletions in the ABHD5 gene. Orphanet J Rare Dis 2010; 5:33.
41. Cakir M, Bruno C, Cansu A, et al. Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5. Acta Paediatr 2010; 99:1592-1594.
42. Samuelov L, Fuchs-Telem D, Sarig O, Sprecher E. An exceptional mutational event leading to Chanarin-Dorfman syndrome in a large consanguineous family. Br J Dermatol 2011; 164:1390-1392.
43. Aggarwal S, Maras JS, Alam S, et al. Novel nonsense mutation of ABHD5 in Dorfman-Chanarin syndrome with unusual findings: A challenge for genotypephenotype correlation. Eur J Med Genet 2012; 55:173-177.
44. Cakmak E, Alagozlu H, Yonem O, et al. Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation. Clin Res Hepatol Gastroenterol 2012; 36:e34-e37.
45. Schweiger M, Schreiber R, Haemmerle G, et al. Adipose triglyceride lipase and hormone-sensitive lipase are the major enzymes in adipose tissue triacylglycerol catabolism. J Biol Chem 2006; 281:40236-40241.
46. Yamaguchi T, Omatsu N, Omukae A, Osumi T. Analysis of interaction partners for perilipin and ADRP on lipid droplets. Mol Cell Biochem 2006; 284:167-173.
47. Granneman JG, Moore HH, Mottillo EP, Zhu Z. Functional interactions between Mldp (LSDP5) and Abhd5 in the control of intracellular lipid accumulation. J Biol Chem 2009; 284:3049-3057.
48. MacPherson RE, Rebecca EK, Ramos SV, et al. Skeletal muscle PLIN proteins, ATGL and CGI-58, interactions at rest and following stimulated contraction. Am J Physiol Regul Integr Comp Physiol 2013; 304:R644-R650.
49. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 2001; 98: 6494-6499.
50. Guillen N, Navarro MA, Arnal C, et al. Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver. Physiol Genomics 2009; 37:187-198.
51. Motomura W, Inoue M, Ohtake T, et al. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet. Biochem Biophys Res Commun 2006; 340:1111-1118.
52. Chang BH, Li L, Paul A, et al. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol 2006; 26:1063-1076.
53. McManaman JL, Bales ES, Orlicky DJ, et al. Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease. J Lipid Res 2013; 54:1346-1359.
54. Imai Y, Boyle S, Varela GM, et al. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Physiol Genomics 2012; 44:1125-1131.
55. Sun Z, Miller RA, Patel RT, et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med 2012; 18:934-942.
56. Listenberger LL, Ostermeyer-Fay AG, Goldberg EB, et al. Adipocyte differentiation-related protein reduces the lipid droplet association of adipose triglyceride lipase and slows triacylglycerol turnover. J Lipid Res 2007; 48:2751-2761.
57. Wang H, Bell M, Sreenivasan U, et al. Unique regulation of adipose triglyceride lipase (ATGL) by perilipin 5, a lipid droplet-Associated protein. J Biol Chem 2011; 286:15707-15715.
58. Granneman JG, Moore HH, Mottillo EP, et al. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase. J Biol Chem 2011; 286:5126-5135.
59. Pollak NM, Schweiger M, Jaeger D, et al. Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier. J Lipid Res 2013; 54:1092-1102.
60. Wang H, Sreenivasan U, Gong D, et al. Cardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction. J Lipid Res 2013; 54:953-965.
61. Schoiswohl G, Schweiger M, Schreiber R, et al. Adipose triglyceride lipase plays a key role in the supply of the working muscle with fatty acids. J Lipid Res 2010; 51:490-499.
62. Badin P, Loubiere C, Coonen M, et al. Regulation of skeletal muscle lipolysis and oxidative metabolism by the co-lipase CGI-58. J Lipid Res 2012; 53: 839-848.
63. Uchida Y, Cho Y, Moradian S, et al. Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome. J Invest Dermatol 2010; 130:2497-2499.
64. Radner FPW, Fischer J. The important role of epidermal triacylglycerol metabolism for maintenance of the skin permeability barrier function. Biochim Biophys Acta 2013. [Epub ahead of print].
65. Williams ML, Coleman RA, Placezk D, Grunfeld C. Neutral lipid storage disease: A possible functional defect in phospholipid-linked triacylglycerol metabolism. Biochim Biophys Acta 1991; 1096:162-169.
66. Igal RA, Coleman RA. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. J Biol Chem 1996; 271:16644-16651.
67. Quiroga AD, Lehner R. Liver triacylglycerol lipases. Biochim Biophys Acta 2012; 1821:762-769.
68. Quiroga AD, Li L, Trotzmuller M, et al. Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia. Hepatology 2012; 56:2188-2198.
69. Lian J, Wei E, Wang SP, et al. Liver specific inactivation of carboxylesterase 3/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice. Hepatology 2012; 56:2154-2162.
70. Reid BN, Ables GP, Otlivanchik OA, et al. Hepatic overexpression of hormone-sensitive lipase and adipose triglyceride lipase promotes fatty acid oxidation, stimulates direct release of free fatty acids, and ameliorates steatosis. J Biol Chem 2008; 283:13087-13099.
71. Ong KT, Mashek MT, Bu SY, et al. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 2011; 53:116-126.
72. Turpin SM, Hoy AJ, Brown RD, et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011; 54:146-156.
73. Brown JM, Chung S, Das A, et al. CGI-58 facilitates the mobilization of cytoplasmic triglyceride for lipoprotein secretion in hepatoma cells. J Lipid Res 2007; 48:2295-2305.
74. Caviglia JM, Sparks JD, Toraskar N, et al. ABHD5/CGI-58 facilitates the assembly and secretion of apolipoprotein B lipoproteins by McA RH7777 rat hepatoma cells. Biochim Biophys Acta 2009; 1791:198-205.
75. Fuchs CD, Claudel T, Kumari P, et al. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice. Hepatology 2012; 56:270-280.
76. Subramanian V, Rothenberg A, Gomez C, et al. Perilipin A mediates the reversible binding of CGI-58 to lipid droplets in 3T3-L1 adipocytes. J Biol Chem 2004; 279:42062-42071.
77. Etschmaier K, Becker T, Eichmann TO, et al. Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers. J Neurochem 2011; 119:1016-1028.
78. Obrowsky S, Chandak PG, Patankar JV, et al. Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARalpha signaling. J Lipid Res 2013; 54:425-435.
79. Chandak PG, Radovic B, Aflaki E, et al. Efficient phagocytosis requires triacylglycerol hydrolysis by adipose triglyceride lipase. J Biol Chem 2010; 285:20192-20201.
80. Lammers B, Chandak PG, Aflaki E, et al. Macrophage adipose triglyceride lipase deficiency attenuates atherosclerotic lesion development in lowdensity lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2011; 31:67-73.
81. Tang T, Abbott MJ, Ahmadian M, et al. Desnutrin/ATGL activates PPARdelta to promote mitochondrial function for insulin secretion in islet beta cells. Cell Metab 2013; 18:883-895.
82. Unger RH, Clark GO, Scherer PE, Orci L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 2010; 1801:209-214.
83. Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: A roadmap to lipotoxicity. Trends Endocrinol Metab 2010; 21:345-352.
84. Bosma M, Kersten S, Hesselink MKC, Schrauwen P. Re-evaluating lipotoxic triggers in skeletal muscle: Relating intramyocellular lipid metabolism to insulin sensitivity. Prog Lipid Res 2012; 51:36-49.
85. Cusi K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology 2012; 142:711-725; e6.
86. Kienesberger PC, Lee D, Pulinilkunnil T, et al. Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem 2009; 284:30218-30229.
87. Monetti M, Levin MC, Watt MJ, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007; 6:69-78.